Insulet | PODD - Assets

Stock Price
147.46
Daily Change
-1.22 -0.82%
Monthly
-26.81%
Yearly
-54.59%
Q2 Forecast
144.50

Insulet reported $2.99B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
AtriCure USD 643.99M 10.19M Mar/2026
Avanos Medical USD 1.05B 23.6M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
ICU Medical USD 4.01B 36.74M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Masimo USD 1.64B 56.2M Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Solventum Corp USD 14.1B 197M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
West Pharmaceutical Services USD 4.11B 160.2M Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026